RHO CAPITAL PARTNERS INC - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.

Quarter-by-quarter ownership
RHO CAPITAL PARTNERS INC ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$57,079,000
-52.7%
1,067,8920.0%31.25%
-24.7%
Q4 2015$120,640,000
-4.0%
1,067,8920.0%41.48%
-0.6%
Q3 2015$125,702,000
+52.0%
1,067,8920.0%41.75%
+44.4%
Q2 2015$82,687,000
+33.8%
1,067,8920.0%28.91%
+12.2%
Q1 2015$61,778,000
+79.4%
1,067,8920.0%25.76%
+68.6%
Q4 2014$34,440,000
+31.8%
1,067,8920.0%15.28%
+16.4%
Q3 2014$26,131,000
+38.0%
1,067,8920.0%13.12%
+78.4%
Q2 2014$18,934,000
-11.4%
1,067,8920.0%7.36%
-11.8%
Q1 2014$21,369,000
-68.7%
1,067,892
-73.7%
8.34%
-76.1%
Q4 2013$68,259,000
+14.3%
4,067,892
-27.6%
34.97%
-4.5%
Q3 2013$59,700,000
+90.0%
5,621,4230.0%36.62%
+43.5%
Q2 2013$31,424,0005,621,42325.52%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 54,476$5,407,0000.30%
CIM INVESTMENT MANAGEMENT INC 3,377$335,0000.14%
MASSMUTUAL TRUST CO FSB/ADV 0$00.00%
EQUITEC SPECIALISTS, LLC 55,700$00.00%
EQUITEC SPECIALISTS, LLC 69,000$00.00%
View complete list of ANACOR PHARMACEUTICALS INC shareholders